Neurology Doctors' Corner

All ALS Dementia Migraine Multiple Sclerosis Parkinson's Disease Seizure Disorder Sleep Disorder Spinal Muscular Atrophy

ALS - Overview

ALS - Treatment

ALS - Dietary Strategy

ALS - Exercise Strategy

ALS - Stress

Articles

ALS

FDA Gives Orphan Drug Designation to Ketamine for ALS

The FDA has recently given orphan drug designation to Ketamine for treatment of Amyotrophic Lateral Sclerosis (ALS)

ALS

Trial Shows Arthritis Treatment Safe for ALS and Eases Inflammation

Tocilizumab, an established rheumatoid arthritis (RA) treatment, was found to reduce inflammation in ALS patients in a new study.

ALS

Cholesterol Metabolism Defects Linked to ALS

A new study published in the Journal of Cell Biology has linked a defect in cholesterol metabolism to the development of neurological damage caused by amyotrophic lateral sclerosis (ALS).

Back To Channels

Send this to a friend